Serum SLPI and MMP9 levels were also increased in patients with CAVD and higher in patients with CAVD and CKD, and our constructed diagnosis nomogram was capable of significantly distinguishing CAVD as well as CAVD in CKD patients. This evidence concerns the gene SLPI and congenital bilateral aplasia of vas deferens from CFTR mutation.